Inventor · disambiguated record
Ian Hiles
Also filed as: HILES IAN · HILES IAN D · HILES IAN DONALD
18 granted patents·1 pending application·318 citations·filing 1993–2007
95Inventor score
Files withLUDWIG INST CANCER RES11CAMBRIDGE NEUROSCIENCE INC4ACORDA THERAPEUTICS INC3CAMBRIDGE NEUROSCIENCE RES1
Top patents by PatentIndex Score
19 records- 0195US5824492APolypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1993·Granted Oct 20, 1998·127 cites·7 claims
- 0285US6274327B1Polypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1998·Granted Aug 14, 2001·40 cites·10 claims
- 0378US6232286B1Methods of stimulating mitogenesis in glial cells using glial mitogenic factorsCAMBRIDGE NEUROSCIENCE RES·Filed 1995·Granted May 15, 2001·27 cites·8 claims
- 0476US7968678B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 28, 2011·1 cites·7 claims
- 0573US5846824APolypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1997·Granted Dec 8, 1998·43 cites·8 claims
- 0672US7319019B1Glial mitogenic factors lacking an N-terminal signal sequenceACORDA THERAPEUTICS INC·Filed 1996·Granted Jan 15, 2008·18 cites·9 claims
- 0767US7541338B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 2, 2009·0 cites·14 claims
- 0863US6147190AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 14, 2000·11 cites·22 claims
- 0961US5854220AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Dec 29, 1998·9 cites·3 claims
- 1057US7135456B1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1995·Granted Nov 14, 2006·8 cites·18 claims
- 1154US2005106666A1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 2004·Application pending·0 cites
- 1249US7422849B1Method for determining expression of a PI3 kinase geneLUDWIG INST CANCER RES·Filed 1999·Granted Sep 9, 2008·5 cites·10 claims
- 1348US7285531B1Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factorLUDWIG INST CANCER RES·Filed 1995·Granted Oct 23, 2007·7 cites·6 claims
- 1447US5741689AMethods to inhibit serine kinase activity and to alter intersubunit binding activity of phosphatidylinositol 3-kinase, and serine kinase active sequence of the sameLUDWIG INST CANCER RES·Filed 1994·Granted Apr 21, 1998·10 cites·28 claims
- 1541US6972280B2Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1996·Granted Dec 6, 2005·5 cites·7 claims
- 1640US7192915B1Methods for treating multiple sclerosis with GGF-related polypeptidesLUDWIG INST CANCER RES·Filed 1996·Granted Mar 20, 2007·1 cites·3 claims
- 1739US6194377B1Methods for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Feb 27, 2001·1 cites·22 claims
- 1838US7094749B1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1996·Granted Aug 22, 2006·4 cites·5 claims
- 1935US6204241B1Method for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Mar 20, 2001·1 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →